Follow us on
SMS-oncology

Providing Direction for successful oncology drug development

Clinical trials are all about obtaining valuable data to show proof of concept, protecting patients and compiling the regulatory dossier, but developing anticancer drugs is a complex business. The right expertise is required to navigate the best way forward. Imagine availing of in-depth knowhow and receiving proactive guidance from oncology trial design to full execution. This will not only give you a head start, but will also allow you to be on top of your data, make informed decisions, mitigate risks and identify opportunities during study conduct.

Offering an integrated approach of clinical operations with expert advice, SMS-oncology sets itself apart from typical CROs by providing Direction during the entire Drug-Data-Dossier path. With our unique “4D” service we are able to give you meaningful insights that will contribute to the successful development of your oncology compound.

Our advantages

Direction
  • Proactively addressing challenges before they turn into hurdles
  • Strategic clinical development advice that can be directly translated into clinical operations
  • Turning complex data into meaningful insights during study conduct using our oncology expertise
Oncology Experts
  • In-depth knowledge of the complex nature of early phase oncology and immuno-oncology studies
  • Dedicated professionals with oncology know-how and experience in all functions of the company
  • Extensive network of Key Opinion Leaders throughout Europe
Responsiveness, Quality & Flexibility
  • Responsive and "right-sized" project teams for close collaboration, flexibility and fast-decision making
  • Close and personal involvement of the management team ensuring a high standard of quality
  • Delivering tailor made solutions by offering full or functional services as needed

Clients

  • AAA
  • BiOrion
  • BliNK Biomedical SAS
  • Cantargia
  • Complix
  • Cristal Therapeutics
  • Delcath Systems
  • eTheRNA
  • Glycostem
  • logo hartwig
  • HYD Pharma
  • Immutep
  • ISA Pharmaceuticals
  • lipo
  • Merus
  • Novalon
  • Pfizer Oncology
  • Prima BioMed
  • Teva Nederland
  • Transimmune
  • UCL Technology Fund
  • VAXIMM
  • logo_xenikos
  • 2-BBB Medicines

News

Cantargia and SMS-oncology conclude agreement on implementation of clinical phase I/IIa trial

16 December 2016

SMS-oncology launches new service "Expert protocol advice (free)"

9 September 2016

SMS-oncology presents poster at CIMT Annual Meeting 2016

10 May 2016

Events

CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference

Mainz/Frankfurt, Germany (6-9 September 2017)

ESMO 2017

Madrid, Spain (8-12 September 2017)

Nordic Life Science Days

Malmö-Copenhagen, Denmark (12-14 September 2017)

Blog & Newsletter

The year after; was the CRA-academy really the gateway to become a great CRA?

22 June 2017

Oncology Highlights - May 2017

2 June 2017

Oncology Highlights - April 2017

8 May 2017
Contact us for more information Request for proposal